Search Results
Results found for "Dominic R Huxley"
- Dr. Raul Gainetdinov | Dr. GPCR Ecosystem
Raul Gainetdinov Raul R. Before SPBU, Raul R. In 2018-2020, Raul R.
- Scott Struthers | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Scott Struthers R. R. Scott Struthers on the web LinkedIn Google Scholar Crinetics Radionetics Dr.
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
John Streicher: Reorganizing Opioid Signaling Beyond the Receptor The dominant strategy for improving With a non-selective HSP90 inhibitor given systemically, the brain effect dominates and pain relief is
- Dr. Peter Robert Banks | Dr. GPCR Ecosystem
These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific
- From Rare Earth Probes to Internalization Assays: The pHSense Story with Dr. Eric Trinquet | Dr. GPCR Ecosystem
story behind pH Sense, Revvity’s innovative GPCR internalization assay, and his journey in GPCR product R& Eric Trinquet is Head of R&D for Life Sciences Reagents at Revvity, where he leads innovation in biochemical
- Dr. Juan José Fung | Dr. GPCR Ecosystem
discovery company focused on targeting GPCR heteromers in cancer, headquartered in Seoul, Korea, with an R&
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
Following this, he joined an early-stage medical device start-up and in 5 years was responsible for project R&
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
Unlike class A receptors, which bind orthosteric ligands within their transmembrane domain and can function as monomers, class C receptors carry an additional extracellular domain of 500 to 600 amino acids that Her work has produced structural data at the extracellular domain level and, more recently, full-length In class C receptors, the orthosteric site sits inside a large extracellular domain that is physically Fan describes the allosteric sites within the transmembrane domain as a more targeted alternative: they
- Dr. Rosie Dawaliby | Dr. GPCR Ecosystem
I have 10 years of experience in the development and management of R&D projects and teams in the field
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
to the GPCR field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&
- Chris Langmead | Dr. GPCR Ecosystem
He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder
- Jennifer Pluznick: Olfactory Receptors in the Kidney and the Gut-Microbe Signal | Dr. GPCR Ecosystem
Pluznick argues they are better understood as chemical sensors that happen to dominate the nose.
- Yamina's Corner | Dr. GPCR Ecosystem
Optimized CRO Collaboration: Streamline internal R&D and external CRO workflows to prevent delays and focused execution accelerates preclinical milestones and maximizes the efficiency and return on your R&
- GPCR Retreat | Dr. GPCR Ecosystem
Conference History The GPCR Retreat is an annual joint meeting with the Club des récepteurs à Sept Domaines the Great Lakes GPCR Retreat partnered with the annual symposium of the Club des Récepteurs à Sept Domains Annual Great Lakes G Protein-Coupled Receptor Retreat held jointly with the Club des Récepteurs à Sept Domaines
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
This challenges the mutation-centric framework that dominates oncology and suggests GPCRs may contribute
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
these questions from a chemical biology perspective - using synthetic peptide analogs, camelid single-domain and Boston Children's Hospital, he developed methods for covalently functionalizing camelid single-domain selectivity: G-protein coupled versus uncoupled states and their downstream consequences Camelid single-domain MIT and Harvard Med School in the lab of Hidde Ploegh , where he developed new applications of single-domain
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
chemists and structural biologists Early-career researchers exploring drug discovery Biotech leaders and R&
- Dr. Christel Menet | Dr. GPCR Ecosystem
I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
therapeutic strategy built around modulators that can be combined, rather than single agents designed to dominate
- Revvity | Dr. GPCR Ecosystem
Revvity, Eric worked for Cisbio Bioassays first as Director of Technological Development and then as R& Elodie DUPUIS R&D Senior project manager, team leader.
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
population-scale GPCR pharmacogenomics The epistemological limits of computational pharmacology without domain Computational skill without pharmacological domain knowledge produces noise, not insight Hauser draws You really need to also combine it with domain knowledge.
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
Bengtsson emphasizes the dominant role of skeletal muscle in metabolic regulation.
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in
- Dr. GPCR Board | Dr. GPCR Ecosystem
My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
Many of the conceptual advances that stemmed from this work, such as the concept of “functional micro-domains
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
The moment when super-resolution imaging revealed nanoscale receptor domains that conventional tools
- Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem
Yamina Berchiche on the web D r.
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
A pharmacologist by training, she spent more than six years in early R&D at Novo Nordisk before turning
- Dr. GPCR Team | Dr. GPCR Ecosystem
During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the
- Trademark Policy | Dr. GPCR Ecosystem
restriction is prohibited by applicable law), and you agree not to register or attempt to register any domain For example, you may not use our marks: In domain names As app icons or featured in an app As the most



























